Company Profile of Beijing Ribio Pharmtech Co., Ltd.

Established in 2017, Beijing Ribio Pharmtech Co., Ltd. is specialized in the field of glycoside, nucleoside and nucleic acid drugs, the main products include 2-deoxy-D-ribose and its derivatives, conventional and modified nucleosides, P-reagents, phosphoramidites, GalNAc delivery vectors, fluorescent labels, linkers and oligonucleotides, etc. Our R&D center is located in Daxing Bio-Pharmaceutical Industry Base, Zhongguancun Science Park, Daxing District, Beijing, equipped with UPLC-MS, HPLC, GC, Polarimeter and other high-end instruments and equipment. The R & D team members are mainly from Peking University, Tsinghua University and other well-known universities at home and abroad with rich experiences in the field of glycoside chemistry, nucleoside chemistry, asymmetric synthesis and nucleic acid drugs, and have developed a variety of raw materials for nucleoside drugs and nucleic acid drugs, furthermore, we have obtained a number of related patents over the years. Our production base is located in Mingxi Economic Development Zone, Fujian Provincial Industrial Park, equipped with 51 sets of different types of reactors, with a total capacity of 150 000 L to meet the production capacity of 100 kilograms to over 100 tons, including specialized production lines for 2-deoxy-D-ribose and nucleoside, and a multi-functional workshop. The analysis department is equipped with HPLC, GC, polarimeter, melting point analyzer and other analysis and inspection equipment. And the base has passed the ISO certifications and supplier audits of pharmaceutical companies from Japan, South Korea, Italy, India, China, etc. We provide raw materials for new product development and pilot scale-up for domestic and foreign pharmaceutical companies and R&D institutions, and provide corresponding technical support!